Finland is well placed to build internationally competitive business in women’s health, according to a report commissioned by the Ministry of Social Affairs and Health.
The report identifies three key measures: targeted funding, more effective use of health data, and measures to facilitate the adoption and market access of new solutions that have been found to be effective.
Finland’s strengths include high-quality research, population-level health datasets and legislation that supports their secure use, biobanks, digital competence and a developing business ecosystem. The report states that Finland could position itself as a leader particularly in data-driven and preventive women’s health.
The report by Healthscape Design, titled ‘Promoting the women’s health sector in Finland – Market analysis and recommendations for measures and policies’, supports the national women’s health strategy that is being prepared by the Ministry of Social Affairs and Health.
“Women’s health and functional capacity do not receive enough attention, and this costs us, both in terms of wellbeing and the economy. At the same time, Finland has strong legislation in place to safeguard research, health data and privacy protection. We also have technological expertise. We must now be able to bring these strengths together in ways that deliver better health for women while also generating new growth for Finland,” says Minister of Social Security Karoliina Partanen.
Women’s health presents both a health gap and growth potential
Women’s health continues to be affected by gaps in treatment, research and knowledge. Women live longer than men, but in Finland women can expect to have around 55.9 healthy life years, which is 2.2 years fewer than men.
Women’s health is also a rapidly growing area of research, technology and business. However, between 2020 and 2025, only around six per cent of private funding for healthcare was directed towards women’s health.
According to the report, the growth of companies in the sector is hindered in particular by limited funding, challenges related to the use of data, and difficulties in gaining market access and deploying new solutions.
Three key measures to boost growth
The report presents six sets of measures, three of which are identified as the most urgent:
Targeted funding. Women’s health should be made one of the priority areas of public funding for growth companies. It is also necessary to have funding for research and clinical validation, as well as growth-stage capital.
Data and clinical validation. Finland’s health registers, research datasets and piloting environments should be used more effectively than at present.
Market access and reimbursement status. More effective ways are needed to pilot and deploy new solutions in both private and public healthcare. There is also a need for predictable regulation and outcomes-based reimbursement models.
The report also proposes a national women’s health strategy and innovation programme, as well as stronger collaboration across the sector.
The report’s indicative objectives suggest that the number of high-growth women’s health companies could double or even triple by 2030. The aim is also to increase the share of health innovation funding allocated to women’s health and promote international research and validation projects in Finland.
The Women’s Health Offering, which is published alongside the report, aims to support the work of Digital Health Finland. It presents Finland’s strengths and the opportunities for cooperation with international partners. The report and the Women’s Health Offering are part of the RDI Growth Programme for Health and Wellbeing coordinated by the Ministry of Social Affairs and Health. This work supports the preparation of the national women’s health strategy.
The strategy is due to be completed in early 2027.
Inquiries
Päivi Sillanaukee, Programme Director, tel. +358 295 163 356, [email protected]
Outi Forsström, Project Manager, tel. +358 295 163 080, [email protected]